Frontier technology, on the path to public.
We back frontier technology and clinical stage biotechnology at the earliest rounds, pre seed and seed, when a clear plan matters more than revenue. Coming in first keeps the cap table clean and the terms simple, and we stay with the company all the way to the public markets.
- Quantum, photonics, advanced compute, clinical biotech Sectors
- Pre seed and seed rounds Stage
- IPO, direct listing, or reverse merger Exit path